Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 81

1.

Discovery of Evobrutinib: An Oral, Potent, and Highly Selective, Covalent Bruton's Tyrosine Kinase (BTK) Inhibitor for the Treatment of Immunological Diseases.

Caldwell RD, Qiu H, Askew BC, Bender AT, Brugger N, Camps M, Dhanabal M, Dutt V, Eichhorn T, Gardberg AS, Goutopoulos A, Grenningloh R, Head J, Healey B, Hodous BL, Huck BR, Johnson TL, Jones C, Jones RC, Mochalkin I, Morandi F, Nguyen N, Meyring M, Potnick JR, Santos DC, Schmidt R, Sherer B, Shutes A, Urbahns K, Follis AV, Wegener AA, Zimmerli SC, Liu-Bujalski L.

J Med Chem. 2019 Sep 12;62(17):7643-7655. doi: 10.1021/acs.jmedchem.9b00794. Epub 2019 Aug 15.

PMID:
31368705
2.

Efficacy and Pharmacodynamic Modeling of the BTK Inhibitor Evobrutinib in Autoimmune Disease Models.

Haselmayer P, Camps M, Liu-Bujalski L, Nguyen N, Morandi F, Head J, O'Mahony A, Zimmerli SC, Bruns L, Bender AT, Schroeder P, Grenningloh R.

J Immunol. 2019 May 15;202(10):2888-2906. doi: 10.4049/jimmunol.1800583. Epub 2019 Apr 15.

3.

Improved survival rates of AML patients following admission to the intensive care unit.

Fassbind P, Jeker B, Mueller BU, Bacher U, Zimmerli S, Endrich O, Gahl B, Novak U, Pabst T.

Leuk Lymphoma. 2019 Apr 3:1-9. doi: 10.1080/10428194.2019.1594213. [Epub ahead of print]

PMID:
30943056
4.

Severe acute respiratory distress syndrome (ARDS) induced by human adenovirus B21: Report on 2 cases and literature review.

Pfortmueller CA, Barbani MT, Schefold JC, Hage E, Heim A, Zimmerli S.

J Crit Care. 2019 Jun;51:99-104. doi: 10.1016/j.jcrc.2019.02.019. Epub 2019 Feb 13.

PMID:
30798099
5.

Revisiting systemic treatment of bacterial endophthalmitis: a review of intravitreal penetration of systemic antibiotics.

Brockhaus L, Goldblum D, Eggenschwiler L, Zimmerli S, Marzolini C.

Clin Microbiol Infect. 2019 Feb 14. pii: S1198-743X(19)30039-4. doi: 10.1016/j.cmi.2019.01.017. [Epub ahead of print] Review.

PMID:
30771529
6.

Bacterial and Fungal Keratitis: A Retrospective Analysis at a University Hospital in Switzerland.

Bograd A, Seiler T, Droz S, Zimmerli S, Früh B, Tappeiner C.

Klin Monbl Augenheilkd. 2019 Apr;236(4):358-365. doi: 10.1055/a-0774-7756. Epub 2019 Jan 7.

PMID:
30616287
7.

Accuracy of Sensititre YeastOne echinocandins epidemiological cut-off values for identification of FKS mutant Candida albicans and Candida glabrata: a ten year national survey of the Fungal Infection Network of Switzerland (FUNGINOS).

Kritikos A, Neofytos D, Khanna N, Schreiber PW, Boggian K, Bille J, Schrenzel J, Mühlethaler K, Zbinden R, Bruderer T, Goldenberger D, Pfyffer G, Conen A, Van Delden C, Zimmerli S, Sanglard D, Bachmann D, Marchetti O, Lamoth F; Fungal Infection Network of Switzerland (FUNGINOS).

Clin Microbiol Infect. 2018 Nov;24(11):1214.e1-1214.e4. doi: 10.1016/j.cmi.2018.05.012. Epub 2018 Jun 15.

PMID:
29909005
8.

Correction to: Prediction of unfavorable outcomes in cryptococcal meningitis: results of the multicenter infectious Diseases International Research Initiative (ID-IRI) cryptococcal meningitis study.

Hakyemez IN, Erdem H, Beraud G, Lurdes M, Silva-Pinto A, Alexandru C, Bishop B, Mangani F, Argemi X, Poinot M, Hasbun R, Sunbul M, Akcaer M, Alp S, Demirdal T, Angamuthu K, Amer F, Ragab E, Shehata GA, Ozturk-Engin D, Ozgunes N, Larsen L, Zimmerli S, Sipahi OR, Tukenmez Tigen E, Celebi G, Oztoprak N, Yardimci AC, Cag Y.

Eur J Clin Microbiol Infect Dis. 2018 Jul;37(7):1241-1242. doi: 10.1007/s10096-018-3281-z.

PMID:
29855841
9.

Correction to: Catheter retention as a consequence rather than a cause of unfavorable outcome in candidemia.

Damonti L, Erard V, Garbino J, Schrenzel J, Zimmerli S, Mühlethaler K, Imhof A, Zbinden R, Fehr J, Boggian K, Bruderer T, Flückiger U, Frei R, Orasch C, Conen A, Khanna N, Bregenzer T, Bille J, Lamoth F, Marchetti O, Bochud PY; Fungal Infection Network of Switzerland (FUNGINOS).

Intensive Care Med. 2018 Mar;44(3):405-407. doi: 10.1007/s00134-018-5081-4.

PMID:
29464298
10.

Fluconazole non-susceptible breakthrough candidemia after prolonged low-dose prophylaxis: a prospective FUNGINOS study.

Orasch C, Mertz D, Garbino J, van Delden C, Emonet S, Schrenzel J, Zimmerli S, Damonti L, Mühlethaler K, Imhof A, Ruef C, Fehr J, Zbinden R, Boggian K, Bruderer T, Flückiger U, Conen A, Khanna N, Frei R, Bregenzer T, Lamoth F, Erard V, Bochud PY, Calandra T, Bille J, Marchetti O; Fungal Infection Network of Switzerland (FUNGINOS).

J Infect. 2018 May;76(5):489-495. doi: 10.1016/j.jinf.2017.12.018. Epub 2018 Jan 31.

PMID:
29378240
11.

Prediction of unfavorable outcomes in cryptococcal meningitis: results of the multicenter Infectious Diseases International Research Initiative (ID-IRI) cryptococcal meningitis study.

Hakyemez IN, Erdem H, Beraud G, Lurdes M, Silva-Pinto A, Alexandru C, Bishop B, Mangani F, Argemi X, Poinot M, Hasbun R, Sunbul M, Akcaer M, Alp S, Demirdal T, Angamuthu K, Amer F, Ragab E, Shehata GA, Ozturk-Engin D, Ozgunes N, Larsen L, Zimmerli S, Sipahi OR, Tukenmez Tigen E, Celebi G, Oztoprak N, Yardimci AC, Cag Y.

Eur J Clin Microbiol Infect Dis. 2018 Jul;37(7):1231-1240. doi: 10.1007/s10096-017-3142-1. Epub 2017 Dec 8. Erratum in: Eur J Clin Microbiol Infect Dis. 2018 May 31;:.

PMID:
29218468
12.

Pharmacokinetics and safety results from the Phase 3 randomized, open-label, study of intravenous posaconazole in patients at risk of invasive fungal disease.

Cornely OA, Robertson MN, Haider S, Grigg A, Geddes M, Aoun M, Heinz WJ, Raad I, Schanz U, Meyer RG, Hammond SP, Mullane KM, Ostermann H, Ullmann AJ, Zimmerli S, Van Iersel MLPS, Hepler DA, Waskin H, Kartsonis NA, Maertens J.

J Antimicrob Chemother. 2017 Dec 1;72(12):3501. doi: 10.1093/jac/dkx382. No abstract available.

PMID:
29029280
13.

Pharmacokinetics and safety results from the Phase 3 randomized, open-label, study of intravenous posaconazole in patients at risk of invasive fungal disease.

Cornely OA, Robertson MN, Haider S, Grigg A, Geddes M, Aoun M, Heinz WJ, Raad I, Schanz U, Meyer RG, Hammond SP, Mullane KM, Ostermann H, Ullmann AJ, Zimmerli S, Van Iersel MLPS, Hepler DA, Waskin H, Kartsonis NA, Maertens J.

J Antimicrob Chemother. 2017 Dec 1;72(12):3406-3413. doi: 10.1093/jac/dkx263. Erratum in: J Antimicrob Chemother. 2017 Dec 1;72(12):3501.

PMID:
28961714
14.

Catheter retention as a consequence rather than a cause of unfavorable outcome in candidemia.

Damonti L, Erard V, Garbino J, Schrenzel J, Zimmerli S, Mühlethaler K, Imhof A, Zbinden R, Fehr J, Boggian K, Bruderer T, Flückiger U, Frei R, Orasch C, Conen A, Khanna N, Bregenzer T, Bille J, Lamoth F, Marchetti O, Bochud PY; Fungal Infection Network of Switzerland (FUNGINOS).

Intensive Care Med. 2017 Jun;43(6):935-939. doi: 10.1007/s00134-017-4737-9. Epub 2017 Mar 7. No abstract available. Erratum in: Intensive Care Med. 2018 Feb 20;:.

PMID:
28271318
15.

Update of the Swiss guidelines on post-treatment Lyme disease syndrome.

Nemeth J, Bernasconi E, Heininger U, Abbas M, Nadal D, Strahm C, Erb S, Zimmerli S, Furrer H, Delaloye J, Kuntzer T, Altpeter E, Sturzenegger M, Weber R, For The Swiss Society For Infectious Diseases And The Swiss Society For Neurology.

Swiss Med Wkly. 2016 Dec 5;146:w14353. doi: 10.4414/smw.2016.14353. eCollection 2016. Review.

16.

Update of the Swiss guidelines on post-treatment Lyme disease syndrome.

Nemeth J, Bernasconi E, Heininger U, Abbas M, Nadal D, Strahm C, Erb S, Zimmerli S, Furrer H, Delaloye J, Kuntzer T, Altpeter E, Sturzenegger M, Weber R, For The Swiss Society For Infectious Diseases And The Swiss Society For Neurology.

Swiss Med Wkly. 2016 Dec 5;146:w14353. doi: 10.4414/smw.2016.14353. eCollection 2016 Dec 5. No abstract available.

17.

Erratum to: Protective effect of TSLP delivered at the gut mucosa level by recombinant lactic acid bacteria in DSS-induced colitis mouse model.

Aubry C, Michon C, Chain F, Chvatchko Y, Goffin L, Zimmerli SC, Leguin S, Langella P, Bermudez-Humaran L, Chatel JM.

Microb Cell Fact. 2016 Nov 10;15(1):188. No abstract available.

18.

Low impact of urine cultures as a diagnostic tool in patients with neutropenic fever.

Steinrücken J, Pabst T, Zimmerli S, Marschall J.

Infect Dis (Lond). 2016 Nov-Dec;48(11-12):872-4. doi: 10.1080/23744235.2016.1205216. Epub 2016 Jul 8. No abstract available.

PMID:
27387039
19.

Immune recovery in HIV-infected patients after Candida esophagitis is impaired despite long-term antiretroviral therapy.

Stuehler C, Bernardini C, Elzi L, Stoeckle M, Zimmerli S, Furrer H, Günthard HF, Leibundgut-Landmann S, Battegay M, Khanna N; Swiss HIV Cohort Study.

AIDS. 2016 Jul 31;30(12):1923-33. doi: 10.1097/QAD.0000000000001126.

20.

Lichtheimia Infection in a Lymphoma Patient: Case Report and a Brief Review of the Available Diagnostic Tools.

Zimmerli S, Bialek R, Blau IW, Christe A, Lass-Flörl C, Presterl E.

Mycopathologia. 2016 Aug;181(7-8):561-6. doi: 10.1007/s11046-016-0010-y. Epub 2016 Apr 26. Review.

PMID:
27115610
21.

Common invasive fungal diseases: an overview of invasive candidiasis, aspergillosis, cryptococcosis, and Pneumocystis pneumonia.

Schmiedel Y, Zimmerli S.

Swiss Med Wkly. 2016 Feb 22;146:w14281. doi: 10.4414/smw.2016.14281. eCollection 2016. Review.

22.

Food allergy in mice is modulated through the thymic stromal lymphopoietin pathway.

Frossard CP, Zimmerli SC, Rincon Garriz JM, Eigenmann PA.

Clin Transl Allergy. 2016 Jan 19;6:2. doi: 10.1186/s13601-016-0090-2. eCollection 2015.

23.

Association of lectin pathway proteins with intra-abdominal Candida infection in high-risk surgical intensive-care unit patients. A prospective cohort study within the fungal infection network of Switzerland.

Osthoff M, Wojtowicz A, Tissot F, Jørgensen C, Thiel S, Zimmerli S, Marchetti O, Khanna N, Bochud PY, Trendelenburg M; Fungal Infection Network of Switzerland (FUNGINOS); Fungal Infection Network of Switzerland FUNGINOS.

J Infect. 2016 Mar;72(3):377-85. doi: 10.1016/j.jinf.2015.12.011. Epub 2015 Dec 28.

PMID:
26730718
24.

Time Course of Antibiotic and Antifungal Concentrations in Corneal Organ Culture.

Seiler TG, Tschopp M, Zimmerli S, Tappeiner C, Wittwer VV, Frueh BE.

Cornea. 2016 Jan;35(1):127-31. doi: 10.1097/ICO.0000000000000671.

25.

Protective effect of TSLP delivered at the gut mucosa level by recombinant lactic acid bacteria in DSS-induced colitis mouse model.

Aubry C, Michon C, Chain F, Chvatchenko Y, Goffin L, Zimmerli SC, Leguin S, Langella P, Bermudez-Humaran L, Chatel JM.

Microb Cell Fact. 2015 Nov 6;14:176. doi: 10.1186/s12934-015-0367-5. Erratum in: Microb Cell Fact. 2016 Nov 10;15(1):188.

26.

Varicella zoster virus reactivation after autologous SCT is a frequent event and associated with favorable outcome in myeloma patients.

Kamber C, Zimmerli S, Suter-Riniker F, Mueller BU, Taleghani BM, Betticher D, Zander T, Pabst T.

Bone Marrow Transplant. 2015 Apr;50(4):573-8. doi: 10.1038/bmt.2014.290. Epub 2015 Jan 19.

PMID:
25599166
27.

Polymorphisms in tumor necrosis factor-α increase susceptibility to intra-abdominal Candida infection in high-risk surgical ICU patients*.

Wójtowicz A, Tissot F, Lamoth F, Orasch C, Eggimann P, Siegemund M, Zimmerli S, Flueckiger UM, Bille J, Calandra T, Marchetti O, Bochud PY; Fungal Infection Network of Switzerland (FUNGINOS).

Crit Care Med. 2014 Apr;42(4):e304-8. doi: 10.1097/CCM.0000000000000208.

PMID:
24557424
28.

Candida species distribution and antifungal susceptibility testing according to European Committee on Antimicrobial Susceptibility Testing and new vs. old Clinical and Laboratory Standards Institute clinical breakpoints: a 6-year prospective candidaemia survey from the fungal infection network of Switzerland.

Orasch C, Marchetti O, Garbino J, Schrenzel J, Zimmerli S, Mühlethaler K, Pfyffer G, Ruef C, Fehr J, Zbinden R, Calandra T, Bille J; FUNGINOS.

Clin Microbiol Infect. 2014 Jul;20(7):698-705. doi: 10.1111/1469-0691.12440. Epub 2013 Dec 12.

29.

β-glucan antigenemia anticipates diagnosis of blood culture-negative intraabdominal candidiasis.

Tissot F, Lamoth F, Hauser PM, Orasch C, Flückiger U, Siegemund M, Zimmerli S, Calandra T, Bille J, Eggimann P, Marchetti O; Fungal Infection Network of Switzerland (FUNGINOS).

Am J Respir Crit Care Med. 2013 Nov 1;188(9):1100-9. doi: 10.1164/rccm.201211-2069OC.

PMID:
23782027
30.

Diagnosis and treatment of mucormycosis in patients with hematological malignancies: guidelines from the 3rd European Conference on Infections in Leukemia (ECIL 3).

Skiada A, Lanternier F, Groll AH, Pagano L, Zimmerli S, Herbrecht R, Lortholary O, Petrikkos GL; European Conference on Infections in Leukemia.

Haematologica. 2013 Apr;98(4):492-504. doi: 10.3324/haematol.2012.065110. Epub 2012 Sep 14. Review.

31.

Emergence of Blastoschizomyces capitatus yeast infections, Central Europe.

Birrenbach T, Bertschy S, Aebersold F, Mueller NJ, Achermann Y, Muehlethaler K, Zimmerli S.

Emerg Infect Dis. 2012 Jan;18(1):98-101. doi: 10.3201/eid1801.111192.

32.

Discovery of potent, selective, and orally bioavailable alkynylphenoxyacetic acid CRTH2 (DP2) receptor antagonists for the treatment of allergic inflammatory diseases.

Crosignani S, Prêtre A, Jorand-Lebrun C, Fraboulet G, Seenisamy J, Augustine JK, Missotten M, Humbert Y, Cleva C, Abla N, Daff H, Schott O, Schneider M, Burgat-Charvillon F, Rivron D, Hamernig I, Arrighi JF, Gaudet M, Zimmerli SC, Juillard P, Johnson Z.

J Med Chem. 2011 Oct 27;54(20):7299-317. doi: 10.1021/jm200866y. Epub 2011 Oct 3.

PMID:
21916510
33.

Breast abscess due to Actinomyces europaeus.

Silva WA, Pinheiro AM, Jahns B, Bögli-Stuber K, Droz S, Zimmerli S.

Infection. 2011 Jun;39(3):255-8. doi: 10.1007/s15010-011-0119-3. Epub 2011 Apr 21.

34.

Zygomycosis in Europe: analysis of 230 cases accrued by the registry of the European Confederation of Medical Mycology (ECMM) Working Group on Zygomycosis between 2005 and 2007.

Skiada A, Pagano L, Groll A, Zimmerli S, Dupont B, Lagrou K, Lass-Florl C, Bouza E, Klimko N, Gaustad P, Richardson M, Hamal P, Akova M, Meis JF, Rodriguez-Tudela JL, Roilides E, Mitrousia-Ziouva A, Petrikkos G; European Confederation of Medical Mycology Working Group on Zygomycosis.

Clin Microbiol Infect. 2011 Dec;17(12):1859-67. doi: 10.1111/j.1469-0691.2010.03456.x. Epub 2011 Jul 1.

35.

Accidental infection of veterinary personnel with Mycobacterium tuberculosis at necropsy: a case study.

Posthaus H, Bodmer T, Alves L, Oevermann A, Schiller I, Rhodes SG, Zimmerli S.

Vet Microbiol. 2011 May 5;149(3-4):374-80. doi: 10.1016/j.vetmic.2010.11.027. Epub 2010 Nov 24.

PMID:
21146334
36.

Intra-aortic balloon pump infection: a neglected nosocomial infection?

Hoffmann M, Bosshard A, Regli B, Zimmerli S, Sendi P.

J Hosp Infect. 2011 Jan;77(1):91-2. doi: 10.1016/j.jhin.2010.07.020. No abstract available.

PMID:
20970885
37.

Survey of aspergillosis in non-neutropenic patients in Swiss teaching hospitals.

Garbino J, Fluckiger U, Elzi L, Imhof A, Bille J, Zimmerli S.

Clin Microbiol Infect. 2011 Sep;17(9):1366-71. doi: 10.1111/j.1469-0691.2010.03402.x. Epub 2010 Dec 3.

38.

Determination of voriconazole in human serum and plasma by micellar electrokinetic chromatography.

Theurillat R, Zimmerli S, Thormann W.

J Pharm Biomed Anal. 2010 Dec 15;53(5):1313-8. doi: 10.1016/j.jpba.2010.05.015. Epub 2010 May 20.

PMID:
20541340
39.

Combined meropenem and linezolid as a systemic treatment for postoperative endophthalmitis.

Tappeiner C, Schuerch K, Goldblum D, Zimmerli S, Fleischhauer JC, Frueh BE.

Klin Monbl Augenheilkd. 2010 Apr;227(4):257-61. doi: 10.1055/s-0029-1245219. Epub 2010 Apr 20.

PMID:
20408069
40.

Dibutyl phthalate-induced thymic stromal lymphopoietin is required for Th2 contact hypersensitivity responses.

Larson RP, Zimmerli SC, Comeau MR, Itano A, Omori M, Iseki M, Hauser C, Ziegler SF.

J Immunol. 2010 Mar 15;184(6):2974-84. doi: 10.4049/jimmunol.0803478. Epub 2010 Feb 19.

41.

Lung cysts.

Sendi P, Springe SD, Zimmerli S.

Am J Med Sci. 2010 Jan;339(1):77. doi: 10.1097/MAJ.0b013e3181af8347. No abstract available.

PMID:
19884820
42.

Keratitis resulting from Thielavia subthermophila Mouchacca.

Theoulakis P, Goldblum D, Zimmerli S, Muehlethaler K, Frueh BE.

Cornea. 2009 Oct;28(9):1067-9. doi: 10.1097/ICO.0b013e31819717f4.

PMID:
19724200
43.

[Does yoghurt gnaw at cardiac valves?].

Noti F, Zimmerli S, Goerre S, Carrel T, Suter T.

Praxis (Bern 1994). 2009 May 13;98(10):547-50. doi: 10.1024/1661-8157.98.10.547. German.

PMID:
19424951
44.

Donor-to-host transmission of Candida glabrata to both recipients of corneal transplants from the same donor.

Tappeiner C, Goldblum D, Zimmerli S, Fux C, Frueh BE.

Cornea. 2009 Feb;28(2):228-30. doi: 10.1097/ICO.0b013e318183a3e3.

PMID:
19158573
45.

Necrotizing fasciitis due to Listeria monocytogenes.

Sendi P, Marti E, Fröhlicher S, Constantinescu MA, Zimmerli S.

Clin Infect Dis. 2009 Jan 1;48(1):138-9. doi: 10.1086/595558. No abstract available.

46.

Clinical characteristics associated with isolation of small-colony variants of Staphylococcus aureus and Pseudomonas aeruginosa from respiratory secretions of patients with cystic fibrosis.

Schneider M, Mühlemann K, Droz S, Couzinet S, Casaulta C, Zimmerli S.

J Clin Microbiol. 2008 May;46(5):1832-4. doi: 10.1128/JCM.00361-08. Epub 2008 Mar 5.

47.
48.

Disseminated tuberculosis following total knee arthroplasty in an HIV patient.

Marschall J, Evison JM, Droz S, Studer UC, Zimmerli S.

Infection. 2008 Jun;36(3):274-8. Epub 2007 Dec 14.

49.

Cutting edge: Lack of evidence for connexin-43 expression in human epidermal Langerhans cells.

Zimmerli SC, Masson F, Cancela J, Meda P, Hauser C.

J Immunol. 2007 Oct 1;179(7):4318-21.

50.

A model of cerebral aspergillosis in non-immunosuppressed nursing rats.

Zimmerli S, Knecht U, Leib SL.

Acta Neuropathol. 2007 Oct;114(4):411-8. Epub 2007 Jun 30.

Supplemental Content

Loading ...
Support Center